Skechers Performance releases a footwear
collection and marketing campaign to support Breast Cancer
Awareness Month
Skechers Performance™, a division of SKECHERS USA, Inc.
(NYSE:SKX), is thrilled to announce its 2016 partnership with
Breast Cancer Care, the only specialist UK-wide charity providing
support for anyone affected by breast cancer. For the first time in
the United Kingdom, Skechers Performance will launch a two-month
marketing programme that includes in-store, digital, print and
social media executions. To commemorate the partnership, Skechers
Performance is releasing a limited edition footwear collection
marked with the iconic breast cancer awareness pink ribbon, which
will be available in SKECHERS retail stores and online, late
September 2016.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20160922005575/en/
Skechers performance supports Breast
Cancer Care (Photo: Business Wire)
"We are proud to partner with Breast Cancer Care and help their
cause, providing care, support and information to help thousands of
people to find a way to live with, through and beyond breast
cancer.” said Peter Youell, SKECHERS UK & Ireland Managing
Director. “After seeing the success of previous partnerships, we
wanted to continue and expand our support for breast cancer
charities in the United Kingdom. In this new collaboration we wish
to help raise awareness about all the incredible free services that
Breast Cancer Care provide, including face-to-face support, vital
information and the confidential Helpline.”
The Skechers Performance Breast Cancer Care collection includes
the Skechers GOrun 400 and GOwalk 3™ styles, and will retail for
£59.00. A donation of £5 per pair sold will be donated to the
foundation. The designs incorporate a black, white and charcoal
colour pallet with the classic pink hue weave-in. Each style also
features the pink ribbon detailing on the heel.
The Skechers GOwalk 3 shoe is available in a slip-on style and
features Skechers’ iconic Goga Mat® technology in the footbed. The
shoe also has responsive flexibility for a more natural movement
and incorporates Goga Pillars™ for added comfort.
Skechers GOrun 400 is designed to be light, comfortable and well
cushioned. The 5GEN® midsole material combined with a biometric
design and breathable mesh upper delivers comfort for your workout.
The shoe is also lined with a unique Goga Run® insole that provides
shock absorption and support.
The limited edition Skechers Performance Breast Cancer Care line
is available at SKECHERS retail stores in the United Kingdom and
online at Skechers.co.uk throughout October. The funds raised will
support Breast Cancer Care, the only specialist UK wide charity
providing support for women, men, family and friends affected by
breast cancer.
Notes to Editor
To learn more about Breast Cancer Care visit
www.breastcancercare.org.uk.
Learn more about Skechers Performance visit www.skechers.co.uk
and follow us on Facebook (facebook.com/SkechersPerformanceUK),
Twitter (twitter.com/SKXPerformance).
About SKECHERS USA, Inc.
SKECHERS USA, Inc., based in Manhattan Beach, California,
designs, develops and markets a diverse range of lifestyle footwear
for men, women and children, as well as performance footwear for
men and women. SKECHERS footwear is available in the United States
and over 160 countries and territories worldwide via department and
specialty stores, more than 1,410 SKECHERS Company-owned and
third-party retail stores, and the Company’s e-commerce website.
The Company manages its international business through a network of
global distributors, joint venture partners in Asia, and
wholly-owned subsidiaries in Brazil, Canada, Chile, Japan, Latin
America and throughout Europe. For more information, please visit
skechers.com and follow us on Facebook (facebook.com/SKECHERS) and
Twitter (twitter.com/SKECHERSUSA).
This announcement contains forward-looking statements that are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements include, without limitation, the Company’s future
domestic and international growth, financial results and operations
including expected net sales and earnings, its development of new
products, future demand for its products, its planned domestic and
international expansion and opening of new stores, the completion
of the expansion and upgrade of the Company’s European Distribution
Center, and advertising and marketing initiatives. Forward-looking
statements can be identified by the use of forward-looking language
such as “believe,” “anticipate,” “expect,” “estimate,” “intend,”
“plan,” “project,” “will be,” “will continue,” “will result,”
“could,” “may,” “might,” or any variations of such words with
similar meanings. Any such statements are subject to risks and
uncertainties that could cause actual results to differ materially
from those projected in forward-looking statements. Factors that
might cause or contribute to such differences include international
economic, political and market conditions including the uncertainty
of sustained recovery in Europe; entry into the highly
competitive performance footwear market; sustaining, managing and
forecasting costs and proper inventory levels; losing any
significant customers; decreased demand by industry retailers and
cancellation of order commitments due to the lack of popularity of
particular designs and/or categories of products; maintaining brand
image and intense competition among sellers of footwear for
consumers; anticipating, identifying, interpreting or forecasting
changes in fashion trends, consumer demand for the products and the
various market factors described above; sales levels during the
spring, back-to-school and holiday selling seasons; and other
factors referenced or incorporated by reference in the Company’s
annual report on Form 10-K for the year ended December 31,
2015 and its quarterly report on Form 10-Q for the three months
ended June 30, 2016. The risks included here are not
exhaustive. The Company operates in a very competitive and rapidly
changing environment. New risks emerge from time to time and the
companies cannot predict all such risk factors, nor can the
companies assess the impact of all such risk factors on their
respective businesses or the extent to which any factor, or
combination of factors, may cause actual results to differ
materially from those contained in any forward-looking statements.
Given these risks and uncertainties, you should not place undue
reliance on forward-looking statements as a prediction of actual
results. Moreover, reported results should not be considered an
indication of future performance.
About Breast Cancer Care
When you have breast cancer, everything changes. Time becomes
measured in appointments. The next scan. The next results. The next
challenge.
At Breast Cancer Care, we understand the emotions, challenges
and decisions you face every day. So, from the day you notice
something’s not right to the day you begin to move forward, we’ll
be here to help you through.
Whether you want to speak to our nurses, download our specialist
information or connect with volunteers who have faced what you are
facing now, we can help you feel more in control.
For care, support and information from day one, call us free on
0808 800 6000 or visit breastcancercare.org.uk
# # #
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160922005575/en/
SkechersMedia:Nicola
Zachariadesnicolaz@eu.skechers.com01707 655 955
Skechers USA (NYSE:SKX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Skechers USA (NYSE:SKX)
Historical Stock Chart
From Sep 2023 to Sep 2024